Bausch Health Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Bausch Health Companies (NYSE/TSX: BHC) announced participation in two upcoming investor conferences. The events include the Cowen & Co. 42nd Annual Health Care Conference on March 8, 2022, at 12:50 p.m. ET, and the Barclays Global Healthcare Conference on March 15, 2022, at 11:15 a.m. ET. Key executives participating include Joseph C. Papa, Sam Eldessouky, and Arthur J. Shannon. Live webcasts will be available on the company's Investor Relations page.

LAVAL, QC, March 3, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate at two upcoming investor conferences.

Joseph C. Papa, chairman and chief executive officer; Sam Eldessouky, executive vice president and chief financial officer; and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the virtual Cowen & Co. 42^nd Annual Health Care Conference on March 8, 2022 at 12:50 p.m. ET and at the Barclays Global Healthcare Conference 2022 in Miami on March 15, 2022 at 11:15 a.m. ET.

A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2022.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

 

Investor Contact:	Media Contact:
Arthur Shannon	Lainie Keller
arthur.shannon@bauschhealth.com	lainie.keller@bauschhealth.com
(514) 856-3855	(908) 927-1198
(877) 281-6642 (toll free)

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-301493445.html

SOURCE Bausch Health Companies Inc.

FAQ

What are the dates and times for BHC's upcoming investor conferences?

Bausch Health Companies (BHC) will participate in the Cowen & Co. conference on March 8, 2022, at 12:50 p.m. ET, and the Barclays Global Healthcare Conference on March 15, 2022, at 11:15 a.m. ET.

Who is speaking on behalf of Bausch Health at the investor conferences?

Key speakers for Bausch Health at the conferences include CEO Joseph C. Papa, CFO Sam Eldessouky, and SVP Arthur J. Shannon.

Where can I find the live webcast for BHC's investor conferences?

The live webcast for Bausch Health's investor conferences can be accessed on their Investor Relations page at https://ir.bauschhealth.com/events-and-presentations/2022.

What is the purpose of Bausch Health's participation in investor conferences?

Bausch Health's participation in these investor conferences aims to communicate their business strategies and financial performance to potential investors.